Junyan Wang1, Mengxuan Niu1, Shuancheng Bai2. 1. Department of ICU, Baotou Central Hospital, Baotou, 014040, Inner Mongolia, China. 2. Department of ICU, Baotou Central Hospital, Baotou, 014040, Inner Mongolia, China. shuanchengbai@sina.com.
Abstract
PURPOSE: This study aims to investigate the effects of long-term infusion of midazolam, propofol, and lytic cocktail on the rat cognitive ability and expression of receptor for advanced glycation end products (RAGE) in the hippocampus. The correlation between cognitive function and RAGE protein expression level could provide basis for clinical application. METHODS: Adult male Wistar rats were first treated with midazolam, propofol, lytic cocktail, and saline solution for 5 consecutive days, respectively, and then their behavioral performance in a Morris water maze was monitored to determine the effects of these sedatives on the cognition of spatial learning and memory. After the behavioral tests, the expression level of RAGE protein in the hippocampus of each rat was determined by ELISA and immunohistochemistry. RESULTS: Compared with the control rats, the sedative-treated rats showed impaired performance in the Morris water maze. These three sedatives rendered similar extents of impairment of learning and memory at the first day after the treatment (p < 0.05, vs. control). However, the impairment by propofol and lytic cocktail gradually reduced in the following days (p < 0.05), while the impairment by midazolam did not show a significant reduction (p > 0.05). In addition, midazolam and propofol, but not lytic cocktail, caused significant upregulation of RAGE expression in the hippocampus. The upregulation of RAGE protein was further corroborated by the increment of RAGE-positive cells in the CA1 region of hippocampus from midazolam- and propofol-treated rats. CONCLUSIONS: The long-term treatment of propofol, midazolam, and lytic cocktail could impair cognition. The upregulation of RAGE protein in hippocampus might play a role in the midazolam- and propofol-caused cognitive dysfunction.
PURPOSE: This study aims to investigate the effects of long-term infusion of midazolam, propofol, and lytic cocktail on the rat cognitive ability and expression of receptor for advanced glycation end products (RAGE) in the hippocampus. The correlation between cognitive function and RAGE protein expression level could provide basis for clinical application. METHODS: Adult male Wistar rats were first treated with midazolam, propofol, lytic cocktail, and saline solution for 5 consecutive days, respectively, and then their behavioral performance in a Morris water maze was monitored to determine the effects of these sedatives on the cognition of spatial learning and memory. After the behavioral tests, the expression level of RAGE protein in the hippocampus of each rat was determined by ELISA and immunohistochemistry. RESULTS: Compared with the control rats, the sedative-treated rats showed impaired performance in the Morris water maze. These three sedatives rendered similar extents of impairment of learning and memory at the first day after the treatment (p < 0.05, vs. control). However, the impairment by propofol and lytic cocktail gradually reduced in the following days (p < 0.05), while the impairment by midazolam did not show a significant reduction (p > 0.05). In addition, midazolam and propofol, but not lytic cocktail, caused significant upregulation of RAGE expression in the hippocampus. The upregulation of RAGE protein was further corroborated by the increment of RAGE-positive cells in the CA1 region of hippocampus from midazolam- and propofol-treated rats. CONCLUSIONS: The long-term treatment of propofol, midazolam, and lytic cocktail could impair cognition. The upregulation of RAGE protein in hippocampus might play a role in the midazolam- and propofol-caused cognitive dysfunction.
Entities:
Keywords:
Cognitive dysfunction; Lytic cocktail; Midazolam; Propofol; RAGE protein
Authors: Xi Chen; Douglas G Walker; Ann Marie Schmidt; Ottavio Arancio; Lih-Fen Lue; Shi Du Yan Journal: Curr Mol Med Date: 2007-12 Impact factor: 2.222
Authors: Ann Marie Schmidt; Barbara Sahagan; Robert B Nelson; Johan Selmer; Robert Rothlein; Joanne M Bell Journal: Curr Opin Investig Drugs Date: 2009-07
Authors: Shannon L Bianchi; Thuy Tran; Chuiliang Liu; Susan Lin; Yujuan Li; Jason M Keller; Roderic G Eckenhoff; Maryellen F Eckenhoff Journal: Neurobiol Aging Date: 2007-03-07 Impact factor: 4.673